Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Meenhorst

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Pharmacy World & Science : PWS|November 24, 1995
Study on didanosine concentrations in cerebrospinal fluid. Implications for the treatment and prevention of AIDS dementia complexD M Burger, C L Kraayeveld, P L Meenhorst, et al.
Pharmacological Research|September 5, 2002
Prognostic factors for the clinical effectiveness of fluconazole in the treatment of oral candidiasis in HIV-1-infected individualsC H W Koks, K M L Crommentuyn, R A A Mathôt, et al.
Pharmacy World & Science : PWS|April 23, 1993
Ocular complications of the acquired immunodeficiency syndrome. Focus on the treatment of cytomegalovirus retinitis with ganciclovir and foscarnetW J Keijer, D M Burger, G H Neuteboom, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|December 30, 1998
Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detectionR P van Heeswijk, R M Hoetelmans, R Harms, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma--drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report studyV R Nannan Panday, R M Hoetelmans, R P van Heeswijk, et al.
The Journal of Infectious Diseases|January 1, 1983
Legionella pneumonia in guinea pigs exposed to aerosols of concentrated potable water from a hospital with nosocomial Legionnaires' diseaseP L Meenhorst, A L Reingold, G W Gorman, et al.
Therapeutic Drug Monitoring|May 22, 2001
Saliva as an alternative body fluid for therapeutic drug monitoring of the nonnucleoside reverse transcription inhibitor nevirapineR P van Heeswijk, A I Veldkamp, J W Mulder, et al.
AIDS (London, England)|July 14, 2000
Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot studyR P van Heeswijk, A I Veldkamp, J W Mulder, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|November 26, 1999
Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detectionA I Veldkamp, R P van Heeswijk, P L Meenhorst, et al.
Therapeutic Drug Monitoring|January 22, 2002
Limited sampling strategies for the estimation of the systemic exposure to the HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapineA I Veldkamp, R P van Heeswijk, J W Mulder, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Pharmacy World & Science : PWS|November 24, 1995
Study on didanosine concentrations in cerebrospinal fluid. Implications for the treatment and prevention of AIDS dementia complexD M Burger, C L Kraayeveld, P L Meenhorst, et al.
Pharmacological Research|September 5, 2002
Prognostic factors for the clinical effectiveness of fluconazole in the treatment of oral candidiasis in HIV-1-infected individualsC H W Koks, K M L Crommentuyn, R A A Mathôt, et al.
Pharmacy World & Science : PWS|April 23, 1993
Ocular complications of the acquired immunodeficiency syndrome. Focus on the treatment of cytomegalovirus retinitis with ganciclovir and foscarnetW J Keijer, D M Burger, G H Neuteboom, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|December 30, 1998
Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detectionR P van Heeswijk, R M Hoetelmans, R Harms, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma--drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report studyV R Nannan Panday, R M Hoetelmans, R P van Heeswijk, et al.
The Journal of Infectious Diseases|January 1, 1983
Legionella pneumonia in guinea pigs exposed to aerosols of concentrated potable water from a hospital with nosocomial Legionnaires' diseaseP L Meenhorst, A L Reingold, G W Gorman, et al.
Therapeutic Drug Monitoring|May 22, 2001
Saliva as an alternative body fluid for therapeutic drug monitoring of the nonnucleoside reverse transcription inhibitor nevirapineR P van Heeswijk, A I Veldkamp, J W Mulder, et al.
AIDS (London, England)|July 14, 2000
Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot studyR P van Heeswijk, A I Veldkamp, J W Mulder, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|November 26, 1999
Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detectionA I Veldkamp, R P van Heeswijk, P L Meenhorst, et al.
Therapeutic Drug Monitoring|January 22, 2002
Limited sampling strategies for the estimation of the systemic exposure to the HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapineA I Veldkamp, R P van Heeswijk, J W Mulder, et al.
Pageof 10